Diabetic retinopathy (DR) is the leading cause of preventable vision impairment among working-age adults.1 Its pathogenesis is multifactorial, characterized by retinal neurodegeneration and microva...
Proliferative diabetic retinopathy (PDR) is the most vision-threatening stage of diabetic retinopathy (DR), a condition increasingly recognized as a neurovascular disorder in which dysregulation of the methionine cycle may impair the retinal neurovascular unit. In this retrospective observational study, targeted metabolomic profiling of the aqueous humor (AH) was performed in 40 eyes from 34 participants categorized into four groups: non-diabetic control individuals; (2) patients without DR; (3) patients with non-proliferative diabetic retinopathy (NPDR); and (4) patients with PDR. Eyes with PDR exhibited markedly elevated homocysteine (fold change 2.31, p < 0.05 vs. controls, with age and diabetes duration acknowledged as potential confounders, given the younger age and longer disease duration in the PDR group) and significantly reduced betaine (fold change 0.61, p < 0.05 vs. NPDR) levels, indicating disruption of the methionine cycle at the neovascular stage. To establish the biological relevance of these findings in AH, in vitro experiments in high-glucose-stimulated human retinal microvascular endothelial cells were performed, which demonstrated that betaine (1,000 μM) significantly suppressed endothelial proliferation, migration, and tube formation (p < 0.01 for proliferation and migration; p < 0.05 for tube formation) compared with high-glucose controls—providing a mechanistic link between the observed aqueous betaine depletion and pathological retinal angiogenesis. In an exploratory subset evaluated with widefield swept-source optical coherence tomography angiography (WF SS-OCTA; 12 eyes from 9 patients), betaine levels were found to be positively correlated with deep vascular complex density (r = 0.734, p = 0.007) and fractal dimension (r = 0.657, p = 0.020), while homocysteine was found to be negatively correlated with superficial vascular parameters (r = −0.623, p = 0.030), suggesting that methionine-cycle imbalance may reflect a broader neurovascular dysfunction. These findings position betaine as a candidate metabolic indicator warranting further investigation in PDR.